RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intercept Pharma appoints Nancy Miller-Rich as director

Nancy Miller-RichIntercept Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has appointed Nancy Miller-Rich to fill a newly created directorship.
Ms. Miller-Rich has 35 years of experience in the healthcare industry, with significant expertise in business development and commercial strategy.

Ms. Miller-Rich served in a number of leadership roles at Merck & Co., Inc. and, prior to the merger of the two companies, at Schering-Plough Corporation.

This is including most recently as Senior Vice President, Global Human Health Business Development & Licensing, Strategy and Commercial Support (2013 – 2017) and Group Vice President, Consumer Care Global New Ventures and Strategic Commercial Development (2007 – 2013).

Prior to joining Schering-Plough in 1990, Ms. Miller-Rich served in a variety of commercial and marketing roles at Sandoz Pharmaceuticals and Sterling Drug, Inc.

She is currently a director of UDG Healthcare plc, as well as a member of the boards of a number of not-for-profit entities.




POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.